AbbVie Stock Price - ABBV

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
AbbVie Inc ABBV NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 71.60 0.00 0.00 0.00 71.60 04:56:16
Stock Trades Traded Volume Average Volume 52 Week Range
2 24 8,542,125 62.66 - 96.60
Last Trade Time Type Quantity Stock Price Currency
04:03:49 10 $ 71.72 USD

AbbVie Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 105.86B 1.48B $ 5.69B 3.68 25.10 1.48B
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
52.54M $ 3.59 5.01% 10/11/19 - -

more financials information »

AbbVie News

Date Time Source News Article
9/17/201916:11Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules..
9/17/201910:48Dow Jones NewsForm 8.3 - Allergan Plc
9/16/201910:15Dow Jones NewsForm 8.3 - Allergan Plc
9/16/201907:57Edgar (US Regulatory)Current Report Filing (8-k)
9/16/201906:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
9/16/201906:09Edgar (US Regulatory)Current Report Filing (8-k)
9/16/201903:02Dow Jones NewsA Plan to Fight Hep C -- WSJ

Latest ABBV Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ABBV Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week68.3872.0968.0670.69088M3.224.71%
1 Month67.3372.0964.4467.71258M4.276.34%
3 Months67.247562.6668.288810M4.366.48%
6 Months81.3484.7362.6671.84468M-9.74-11.97%
1 Year95.3596.662.6677.22267M-23.75-24.91%
3 Years63.62125.8655.062380.90556M7.9812.54%
5 Years59.6125.8645.4571.06697M1220.13%

AbbVie Description

AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013.
Your Recent History
NYSE
ABBV
AbbVie
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190918 09:58:41